Virology Conferences | Microbiology Conferences | World Congress| Madrid | Europe | USA | 2016

Theme: An Insight on Advances in Virology and Infectious Diseases

Euro Virology 2016

Euro Virology 2016

OMICS International pleasantly proposes you to attend the "6th Euro Virology Congress and Expo" to be held on March 10-12, 2016 at Madrid, Spain. The cynosure of the conference is an “Insight on Advances in Virology and Infectious Diseases”. The conference invites connoisseurs from all pre-eminent universities, research institutions, microbiologists, virologists and diagnostic companies to share their research sentiences’ on all aspects of this rapidly augmenting field and emblazoning the recent advancements and technologies being currently used and the ones being developed on futuristic technologies for further research on viruses.

Track 1: Viral Evolution & General Virology

The Global Virology Industry has a Turn Over of $1485.02 million in 2013 and it is imminent that it will reach $1932.8 million by 2018 at a CAGR of about 5.6% since 2013. Spain is one of the major countries where the industry is getting serendipitous every year as researchers are showing superlative interest in microbiological studies.

Viral evolution is a sub-discipline of evolutionary biology and virology that is judiciously concerned with the evolution of viruses. Many infections, in specie RNA infections, have short interims and conservatively high change rates (on the request of one mark transformation or more per genome per sequence of replication for RNA viruses). Virus Genomes are prominently small and they are prodigiously contradistinctive and are liable to a diligent genetic change. Viral infections remain one of the prominent causes of human and animal diseases. Viral replication is the inception of biological viruses amidst the infection in the target host cells. Viruses have their inherent ways of transmission. The mobility of animals ennobles the mechanisms of viral Transmission that have evolved, whereas plants remain riveted and thus virus devoir relies on environmental elements to be transmitted between hosts. Pathogenetic Factors that affect pathogenic mediations are (1) opportuneness of virus to the tissue, (2) cell susceptibility to virus multiplication & (3) virus susceptibility to host defenses.

Track 2: HIV & Other Emerging Viruses affecting Afro-Asian Continents

The universal HIV/AIDS industry including up-scale commodity and generics was appraised at $11.3 billion in the year 2010. This industry is imminent that the surge will be at a 4.6% compound annual growth rate (CAGR) to reach $14.1 billion in 2016-2017.

Viral entry is the incipient stage of infection in the viral life cycle, as the virus impinges with the host cell and infiltrates viral material into the cell. The human immunodeficiency virus is a lenti-virus (sub-group s of viruses) that incite HIV infection and acquired immunodeficiency syndrome. HIV diagnosis is accomplished by testing blood or saliva for antibodies specific to the virus. HIV/AIDS clinical trials are research executed to review advanced ways to impede, detect or treat HIV/AIDS. Clinical Trials are the most expeditive ways to adjudge the advanced medical concepts to combat HIV/AIDS are safe, verifiable and efficient and conclusive in people. Diseases pertinent with HIV are Tuberculosis (TB), Salmonellosis, Candidiasis, Cryptococcal meningitis, Toxoplasmosis and Cryptosporidiosis. Influenza, extensively known as the flu, is an infectious disease actuated by the Influenza Virus. There are two primitive strains of influenza virus: Types- A and B. The strains of influenza A and B viruses that consistently spread in people are culpable for perennial flu epidemics every year. Influenza A viruses can be fragmented into sub-types ancillary to the genes that are frame work of the surface proteins. Over the stint of the flu season, diverse types (A & B) and sub-types (influenza A) of influenza virus dispel and incite illness.

In Viral meningitis , the inflammation of the meninges (the sheath camouflaging the brain & spinal cord) prevails; incited by an infection. Chickenpox is induced by Varicella, a Herpes virus; Also called as Varicella-Zoster or Human Herpes Virus-3. Apparently, the Varicella Virus could lay dormant in the nerve roots and cause the Zoster (shingles) eventually in life. This eventual infection is called the Herpes Zoster Virus Infection. Predominantly 12% of human cancers are induced by oncoviruses. Severe acute respiratory syndrome (SARS), one of the viral respiratory disease is of a zoonotic inception caused by SARS-coronavirus (SARS-CoV). In the span of 9 months, between November 2002 & July 2003, a scourge of SARS in Southern China affected about 8,096 people and caused an eventual 774 deaths. Innumerable cases were reported in countless countries with the preponderant cases in Hong Kong. Polio Virus is another human entero-virus and a member of the family of Picornaviridae. Ebola is a disease of humans and primates, which are induced by Ebola viruses. The disease has a tremendous risk of death, annihilating between 25 and 90% of those infected, on an average of about 50%; Often due to low blood pressure caused due to fluid loss and consistently follows six to sixteen days after the initial symptoms appear.

6th Euro Virology Congress and Expo March 10-12, 2016, Spain; 2nd World Congress on Infectious Diseases, August 25-27, 2016, USA; 2nd International Conference on Influenza September 12-14, 2016, Germany; 2nd International Conference on Retroviruses & Novel Drugs, June 30-July 01, 2016, South Africa; HIV Vaccines, March 20—24, 2016, California, USA

Track 3: Viral Hepatitis

Requital to the immense infection of HCV and urgency for the advanced and enhanced therapies, there are a myriad of assessments prognosticating the universal industry for HCV treatment will reach $20 billion perennially by the end of this decapod.

Hepatitis is a medical indisposition delineated by the inflammation of the liver and elucidated by the presence of inflammatory cells in the tissues of the organ. Hepatitis A is an acute infectious disease of the liver induced by hepatitis A virus while Hepatitis B is an infectious disease induced by hepatitis B virus (HBV) which affects the liver. It causes both acute and chronic hepatitis infections. HCV is spread chiefly by blood-to-blood contact associated with employing intravenous use of drugs and by erroneously sterilized medical equipments, and transfusions.

6th Euro Virology Congress and Expo March 10-12, 2016, Spain; 2nd International Conference on Retroviruses & Novel Drugs, June 30-July 01, 2016; 2nd World Congress on Infectious Diseases, August 25-27, 2016, USA; 2nd International Conference on Influenza September 12-14, 2016, Germany; South Africa; HIV Vaccines, March 20—24, 2016, California, USA

Track 4: Vaccines and Viral Vectors

The vaccine technology industry is anticipated to reach $57,885.4 million by 2019 from the previous $33,140.6 million of 2014, at about a CAGR of 11.8%. Chief elements driving amelioration of vaccine technology industry include rising prepotence of diseases, increasing government initiatives for elevating ecumenical immunizations, increasing company investments in vaccine development, and expanding initiatives by non-governmental organizations for vaccinations. The ecumenical market for cancer vaccines is anticipated to grow to $4.3 billion by the year 2019, with about a five-year compound annual growth rate (CAGR) of 1.3%.

The pre-eminent ameliorate of viral vectors is the persistent expression of the gene of interest and a diminished need for repeated dosage. In addition, this approach is particularly proficient at exhorting T-lymphocyte activation. Antigens are thus perceived in the context of T-cell immunity, a cardinal defense against many viral infections and parasitic diseases for instance, malaria. Antiviral vaccines have been the relatively effectual biomedical supervention for preventing epidemic viral disease. Although rudimentary vaccines were developed analytically by ingression into live animals or eggs particularly; more recent vaccines have been developed because of the accession of new technologies, circumspectly cell culture and molecular biology. Scientists have taken many approaches in devising vaccines antihetic to a microbe. DIVA Vaccines (Differentiating Infected from Vaccinated Animals) make it feasible in differentiating the infected from the vaccinated animals.

Track 5: Agriculture and Plant Virology

The agricultural inoculants industry when quoted in appraisal is envisaged to reach about $398.56 million by the year 2019, at a CAGR of about 9.5% from 2014.

The epidemiology of plant virus diseases obligates the cyclical development of virus diseases visceral to plant populace in time and expanse. Tobacco mosaic virus (TMV) is a positive-sense single stranded RNA virus that infects an extensive expanse of plants, principally tobacco and other members of the family Solanaceae. Mycology is the field of biology which accords with the study and research on fungi, constituting their genetic, biochemical properties, taxonomy & their use to humans as a reservoir for tinder, medicine, wine and various entheogens, as well as the perils like poisoning/noxiousity or infection. Viruses exist as obligate intracellular parasites and hence they ought to accomplish unambiguous approaches of transmission, between hosts, in order to endure. 75% of plant viruses have genomes that compose single stranded RNA (ssRNA). 65% of plant viruses have +ssRNA, in essence that they are in the same sense proclivity as messenger RNA but 10% have -ssRNA, in essence they ought to be converted to +ssRNA precedently to being translated. 5% are double stranded RNA and so can be promptly translated as +ssRNA viruses.

Track 6: Clinical & Neuro Virology

Clinical Trial Management System (CTMS) Universal Industry’s Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019 asserts that the comprehensive clinical trial management systems industry, which was priced at $844 million in 2013, will elevate at a CAGR of about 14% by 2019 to aggregate net worth of an envisaged $1,848.5 million by 2019.

Clinical Virology is a field of medicine consisting of disengaging &/or illustrating one or more diseases amenable for omnifarious human pathologies by variegated and agile technologies. It conjointly constitutes corroboration of the truancy of viral resistance in anti-viral treatment by viral genome sequencing to acclimate antiviral therapeutics at the best undertaking. Neurovirology is a multifaceted field which is a consolidation of Clinical Neuroscience, Virology, Immunology and Molecular Biology. The premier crux of the field is to scrutinize the infections that depreciate the sensory system. Vector-borne infections are the contagions imparted by contagious arthropod species, for instance, mosquitoes, ticks, sand-flies, black-flies, etc., A blood-borne disease dissipates through contaminated blood and other contaminated body fluids. Diagnostic Virology is one of the main-stream practices of the Medical Virology and diverse systems are employed for the laboratory diagnosis of viral contaminations, including Viral Populace, Antigen Identification, Nucleic Corrosive Location and Serology. There are incongruous tools for diagnosing Neuroviral infections.

6th Euro Virology Congress and Expo March 10-12, 2016, Spain; 2nd International Conference on Retroviruses & Novel Drugs, June 30-July 01, 2016, South Africa; 2nd World Congress on Infectious Diseases, August 25-27, 2016, USA; 2nd International Conference on Influenza September 12-14, 2016, Germany; 17th International Workshop on HIV Persistence during Therapy, 8 – 11 December 2015, Miami; 23rd Conference on Retroviruses and Opportunistic Infections (CROI 2015)22 – 25 February 2016, Boston; Gene Expression and Signaling in the Immune System, April 26 - 30, 2016, USA

Track 7: Paediatric Viral Diseases

EAC anticipates that the viral industry will elevate from previous ecumenical/global size of $4.2 billion to $6.9 billion this year (2016), indicating a compound annual growth rate (CAGR) of about 10.6%

Viral diseases are supposedly the dire adjudge for juvenile forlornness and fatality across the globe. In a myriad of developing nations in the South-East Asia and Western Pacific, the emphasis on various health nuisances assimilate profound respiratory contaminations, diarrheas and arbo-viral diseases. Research conducted on these diseases demonstrate that there is no momentous discrepancies in the aetiological agents that are comprised or in the arrayal of clinical juvenile disease. Myocarditis is a disease of both adult and paediatric patients; it is an inflammatory disorder, customarily caused by viral infections. Hand-foot and mouth disease, herpangina, aseptic meningitis & pleurodynia are prevalent viral diseases in paediatric patients.

Track 8: Therapeutic Approaches & Targets for Viral Infections

The Universal Microbiology Industry at an envisaged $1485.02 million way back in 2013 is imminent to reach $1932.8 million by the year 2018, at a CAGR of about 5.6%.

Antiviral drugs are an assortment of medications certified to treat a myriad of viral infections. DNA immunization is a neoteric approach used to consciously trigger humoral & cellular immune responses towards protein antigens. Viral vaccines comprise either inactivated viruses or attenuated viruses. Oncolytic virotherapy is an emanating treatment expedient which utilizes replication efficient viruses to annihilate cancers. Breakthrough in the preceeding two years assimilate preclinical indication of attainability for a solitary shot virotherapy, Identification of varied medications that revitalizes intra-tumoral infection stimulation, new approaches to augment immunotherapeutic efficiency of oncolytic virotherapy & clinical assertion of a eclectic viremic edge for vascular transmission and intratumoral viral replication.

Annual Congress on Rare Diseases Orphan Drugs May 12-13, 2016,USA; 2nd World Congress on Infectious Diseases, August 25-27, 2016, USA; 2nd International Conference on Influenza, September 12-14, 2016, Germany; 3rd World Congress on Hepatitis and Liver Diseases October 17-19, 2016, UAE; 23rd Conference on Retroviruses and Opportunistic Infections (CROI 2015), 22 – 25 February 2016, Boston; Retroviruses, May 23 - 28, 2016, Harbor, USA; HIV Vaccines, March 20—24, 2016, California, USA

Track 9: Tumour Virology and Immunology

The Ecumenical Cancer/Tumour Profiling Industry was worth $13.30 billion in the year 2012 & is envisaged to reach around $35 billion by the year 2018, growing at a CAGR of about 18.50% from 2013.

Viral Gastroenteritis is a viral infection which causes the inflammation of stomach and intestines; also called as stomach flu. Hepatocellular carcinoma is a typical liver cancer. Human Papillomaviruses (HPVs) are the causative agents of varied human tumours, comprising cervical cancer, which is the primary cause of cancer related mortalities in women across the globe. Simian virus 40(SV40), is a polyomavirus that is common to both humans and primates. It was named after the profound and specific effect it had on infected green monkey cells, by developing an unusual number of vacuoles in the cells.

Track 10: Host Immune Defences & Immunotherapy

The universal cancer immunotherapy industry is expected to grow to nearly $67.9 billion in 2018 from the $34.3 billion of 2013 and with a compound annual growth rate (CAGR) of about 14.7% from 2013.

Immunotherapy can be illustrated as the therapy to galvanize or restore the competency of the resistant (protection) contour to encounter disease and disorder. Organic treatment, similarly utilizes the body's typical capabilities that comprises the impenetrable contour to encounter a myriad of diseases and infections & to veneer the body from the side-effects of the treatment. Chemotherapy & radiation therapy are the most competent treatment perspectives for encountering cancer. Monoclonal antibodies are made use of in treating varied cancers. To prepare a monoclonal antibody, scientists initially have to diagnose the precise antigen to encounter. Acquired resistance happens when a definite microorganism achieves the capability to resist the action of the antimicrobial agent to which the microbe was initially susceptible; This happens because of the transformation of varied qualities comprised in typical physiological processes and cell structures or from imbibing resistance aspects or from a fusion of these mechanisms.

2nd International Conference on Retroviruses & Novel Drugs, June 30-July 01, 2016, South Africa; 6th Euro Virology Congress and Expo March 10-12, 2016, Spain; International conference on Human Papillomavirus May 02-03, 2016, USA; International Conference on Virology and Infectious Diseases, Thailand; 23rd Conference on Retroviruses and Opportunistic Infections (CROI 2015) 22 – 25 February 2016, Boston; Gene Expression and Signaling in the Immune System, April 26 - 30, 2016, USA;

Track 11: Veterinary Virology

The universal animal healthcare industry was worth $27,861.2 million in 2013 and is envisaged to grow at a CAGR of 7.1% from 2014 to reach an estimated $41,929.1 million by 2019.

Veterinary Virology, the study of viruses in animals is a significant sub-field of veterinary medicine and virology. An Emerging virus is a newly discovered virus which increases in incidence or with the feasibility of surge in its incidence. Zoonotic diseases/infections are spontaneously impartible from vertebrates (animals) to humans. Transmissible spongiform encephalopathies (TSEs) known as prion diseases characterize an assortment of conditions that indispose the nervous system in both the humans and animals. Pestivirus infect only mammals, including members of the family Bovidae (cattle, sheep and goats) and the family Suidae (species of swine). The arterivirus is a myriad of infections. These are acutely species specific, yet share innumerable organic & sub-atomic characteristics, like for instance virion morphology, arrangement of basic proteins, Viral genome associations & viral replication system, also the capacity to set up various delayed or genuine determined contamination in hosts.

Global Veterinary Summit and Expo, July 18-20, 2016, Chicago, USA ; 7th World Congress on Virology November 21-23, 2016 Baltimore, USA; 4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Miami, USA; 2nd World Congress on Infectious Diseases August 25-27, 2016; 32nd Clinical Virology Symposium,May 19-22, 2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26,2016, Argentina; 10th Asia-Pacific Congress of Medical Virology,Oct 15-18, 2016 Taiwan; 26th Annual Meeting of the Society forVirology, April 6-9,2016 Germany; 14th International Symposium on NeuroVirology, 2016, Canada.

Track 12: Drug Discovery Program

The ecumenical industry for drug discovery technologies & products was worth $38.4 billion in 2011 and is envisaged to grow to about $79.0 billion in 2017, at a compound annual growth rate (CAGR) of about 13.8% till 2017. Visiongain, an autonomous media association quartered in London, reported that the world industry for drug discovery outsourcing reached $16.6 billion in 2015.

Drug –Drug Interactions transpire when a drug inter-react or intrude another drug. This can impinge the course the drugs- either one or both drugs react in the body and in some cases, also cause unanticipated side effects. The cognate drugs can be either prescription medications or over-the-counter (OTC) medicines, even vitamins and herbal medicines. Clinical trials are quite agile in determining advanced medical pursuits to cure diseases are unerring, safe and efficient in people. Pre-clinical methods are used to arbitrate the activity of new drugs in animals. Drug design relies on the expertise of the three-dimensional frame-work of the bio-molecular target, notorious as structure-based drug design.

Annual Congress on Rare Diseases Orphan Drugs May 12-13, 2016,USA; 2nd International Conference on Retroviruses & Novel Drugs, June 30-July 01, 2016; 2nd International Conference on Influenza September 12-14, 2016 Berlin, Germany; 3rd World Congress on Hepatitis and Liver Diseases October 17-19, 2016, UAE; 2nd International Conference on Flu November 17-19, 2016, USA; Palm Springs Symposium on HIV/AIDS, March 3-5, 2016 Palm Springs, California

Track 13: Recent Advances in Viral Therapy

The universal industry for drug discovery technologies & products was worth $38.4 billion in 2011 and is anticipated to grow to about $79.0 billion by 2017, at a compound annual growth rate (CAGR) of about 13.8% till 2017. Visiongain, an autonomous media association quartered in London, reported that the world industry for drug discovery outsourcing reached $16.6 billion in 2015.

Gene delivery is a mechanism in which foreign DNA is transmitted to the host cells for various applications like genetic research/gene therapy. Gene delivery methods can be either Mechanical like microinjection, electroporation or biolistics; or Chemical like lipid or nanoparticle carriers or Biological like viral or bacterial vectors. Scientists engaged on approaches analogous to rational drug design for progressive antivirals focused on besieging viruses at every phase of their life cycles. Monoclonal antibodies are employed in treating many diseases including varied cancers. In preparation of a monoclonal antibody, researchers first have to diagnose the precise antigen to encounter.

Annual Congress on Rare Diseases Orphan Drugs May 12-13, 2016, USA; 3rd International Conference on Chronic Obstructive Pulmonary Disease July 11-12, 2016, Australia; 2nd International Conference on Influenza September 12-14, 2016 Berlin, Germany; 3rd World Congress on Hepatitis and Liver Diseases October 17-19, 2016, UAE; 2nd International Conference on Flu November 17-19, 2016, USA; 23rd Conference on Retroviruses and Opportunistic Infections (CROI 2015) 22 – 25 February 2016, Boston; Gene Expression and Signaling in the Immune System, April 26 - 30, 2016, USA; HIV Vaccines, March 20—24, 2016, California, USA; 7th International Workshop on HIV Persistence during Therapy, 8 – 11 December 2015, Miami.

Track 14: Current Focus in Virology Research

The universal stem cell therapy industry is poised to grow at a CAGR of about 39.5% from 2015 to 2020 and is estimated to reach $330million by 2020.

Stem cell therapy makes use of stem cells to ameliorate or impede a disease or other indisposition. Bone marrow transplant is the predominantly executed stem cell therapy, while few therapies proximating from the umbilical cord blood are also adapted. Clinical or medical virology is an intermediary field of medicine consisting of isolating and/or characterizing viruses liable for varied human pathologies by either direct or indirect approaches.

7th World Congress on Virology November 21-23, 2016 Baltimore, USA; 4th International Conference on HIV/AIDS, STDS and STIS October 03-05, 2016 Miami, USA; 2nd World Congress on Infectious Diseases August 25-27, 2016; 32nd Clinical Virology Symposium, May 19-22,2016 Florida, USA; IV International Clinical Virology Symposium and Advances in Vaccines Oct 24-26, 2016 Argentina;10th Asia-Pacific Congress of Medical Virology, Oct 15-18, 2016 Taiwan; 26th Annual Meeting of the Society for Virology, April 6-9, 2016, Germany; 14th International Symposium on NeuroVirology, 2016, Canada.

OMICS International welcomes you to attend the "6th Euro Virology Congress and Expo" during March 10-12, 2016 at Madrid, Spain. This conference is focusing on the theme “An Insight on Advances in Virology and Infectious Diseases”. The conference invites participants from all leading universities, research institutions, microbiologists, virologists and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the recent advancements and technologies being used and developed for the research on viruses.

Euro Virology 2016 welcomes attendees, presenters, and exhibitors from all over the world to Spain. We are delighted to invite you all to attend and register for the “Virology 2016” which is going to be held during March 10-12, 2016 at Madrid, Spain. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Euro Virology-2016, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Euro Virology 2016 organizing committee look forward to meet you at Madrid, Spain.

For more details visit: http://virology.omicsgroup.com/europe

Importance & Scope:

Virology is the study of viruses – submicroscopic, parasitic particles of genetic material contained in a protein coat and virus-like agents. Virology is often considered a part of microbiology or of pathology. Viruses and viral diseases have been at the centers of science, agriculture, and medicine for millennia and some of our greatest challenges and triumphs have involved virology. Our virology conference is bringing experts from the field of virology for discussion of the latest advances and ideas and to stimulate interdisciplinary interactions. Conference like ours will help to speed up of the development of effective therapies for viral disorders.

Conference Highlights:

· General Virology and Basic Science

· Cinical and Neuro Virology

· Respiratory and Emerging/Re-emerging Viruses

· Agriculture and Plant Virology

· Therapeutic Approaches and Targets for Viral Infections

· Veterinary Virology

· Organ specific Cancer and Tumor virology

· Regulatory and Economical Aspects in Virology

· Recent Advances in Drug Discovery

· Current Focus in Virology Research

Top Societies and Association around the World

· Center for Emerging Viral Infections Research

· Hunter Medical Research Institute

· Center for Global Research and Intervention in Infectious Diseases

· Infectious and Immunologic Diseases Research Center

· Global virus network

· HIV Medicine Association

· International AIDS Society

· Canadian Society for International Health

Target Audience:

Microbiologists, Virologists, Scientists, Researchers, Students, Industrial delegates from both Academia and Research along with the Industrial professionals, Technologists from Microbiology & Virology companies and various healthcare sectors.

A Unique Opportunity for Advertisers and Sponsors at this International event.

Summary: Euro Virology 2016 welcomes attendees, presenters, and exhibitors from all over the world to Spain. We are delighted to invite you all to attend and register for the “Virology 2016” which is going to be held during March 10-12, 2016 at Madrid, Spain. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Euro Virology-2016, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Euro Virology 2016 organizing committee look forward to meet you at Madrid, Spain.

For more details visit: http://virology.omicsgroup.com/europe

Importance & Scope:

Conference Highlights:

General Virology and Basic Science
Cinical and Neuro Virology
Respiratory and Emerging/Re-emerging Viruses
Agriculture and Plant Virology
Therapeutic Approaches and Targets for Viral Infections
Veterinary Virology
Organ specific Cancer and Tumor virology
Regulatory and Economical Aspects in Virology
Recent Advances in Drug Discovery
Current Focus in Virology Research

Top Societies and Association around the World

Center for Emerging Viral Infections Research
Hunter Medical Research Institute
Center for Global Research and Intervention in Infectious Diseases
Infectious and Immunologic Diseases Research Center
Global virus network
HIV Medicine Association
International AIDS Society
Canadian Society for International Health

Statistical Analysis of Associations

Figure 1: Statistical Analysis

Source: reference 1

Target Audience:

Scientists
Research Scholars
Associate Professors
Professors
Lecturers
M.Sc Students
Pharmaceutical Industries
Healthcare Industries
Directors of Associations and Societies

Target Audience:

Industry 40%

Academia 60%

Others 10%

Figure 2: Target Audience

Companies Associated with Virology

Figure 4: Companies Associated with Virology

Source-reference 3

Research Institutes and Labs Associated with Virology

Figure 5: Research institutes and labs Associated with Virology

Source-reference 4

Statistics of Scientists working on Virology:

Figure 6: No. of Scientists working on virology.

References:

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	March 10-12, 2016
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2	Day 3
Poster Opportunity Closed	Click Here to View

6^th Euro Virology Congress and Expo March 10-12, 2016 Madrid, Spain

Recommended Global Microbiology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Euro Virology 2016

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues